Evergreen capital base enables BroadOak to pursue its life sciences growth capital strategy over a longer

BroadOak Capital Partners is proud to support Codis, building on the company’s scale, quality, and global

BroadOak Capital Partners is an investor in Codis – formerly Particle Dynamics. The full press release

BroadOak Capital Partners advised the Board of Directors of Enzo Biochem on strategic alternatives and the

BroadOak Capital Partners advised Scientific Industries on the divestiture of its Genie division. The full press

We’re pleased to share that Pluristyx, a BroadOak Capital Partners portfolio company, has recently completed an

We’re pleased to share that Particle Dynamics, a BroadOak Capital Partners portfolio company, has acquired EuroAPI

BroadOak Capital Partners is pleased to share that Halo Labs has been acquired by Waters Corporation.

BroadOak Capital Partners is pleased to share that Rubicon Founders has invested in Horizon Infusions. BroadOak